{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:16:22Z","timestamp":1777540582397,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1007\/s11908-003-0073-z","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T12:03:14Z","timestamp":1180094594000},"page":"194-198","source":"Crossref","is-referenced-by-count":36,"title":["Etiology and management of recurrent aphthous stomatitis"],"prefix":"10.1007","volume":"5","author":[{"given":"Martin S.","family":"Greenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"73_CR1","first-page":"18","volume":"94","author":"Y Kim","year":"2001","unstructured":"Kim Y, Greenberg MS: Management of patients with severe oral mucosal disease. Alpha Omegan 2001, 94:18\u201323.","journal-title":"Alpha Omegan"},{"key":"73_CR2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1085-5629(97)80017-X","volume":"16","author":"RS Rogers","year":"1997","unstructured":"Rogers RS: Recurrent aphthous stomatitis: clinical characteristics and associated systemic disorders. Semin Cutan Med Surg 1997, 16:278\u2013283.","journal-title":"Semin Cutan Med Surg"},{"key":"73_CR3","first-page":"95","volume":"31","author":"JA Ship","year":"1999","unstructured":"Ship JA, Chavez EM, Doerr PA, et al.: Recurrent aphthous stomatitis. Quint Int 1999, 31:95\u2013112. Comprehensive review on RAS, etiology, and management.","journal-title":"Quint Int"},{"key":"73_CR4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1079-2104(96)80403-3","volume":"81","author":"J Ship","year":"1996","unstructured":"Ship J: Recurrent aphthous stomatitis: an update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996, 81:141\u2013147.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"73_CR5","first-page":"728","volume":"132","author":"CE Jr","year":"2001","unstructured":"CE Jr, Aphthous ulcers revisited. J Am Dent Assoc 2001, 132:728.","journal-title":"J Am Dent Assoc"},{"key":"73_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0738-081X(00)00147-4","volume":"18","author":"SR Porter","year":"2000","unstructured":"Porter SR, Hegarty A, Kaliakatsou F, et al.: Recurrent aphthous stomatitis. Clin Dermatol 2000, 18:569\u2013578.","journal-title":"Clin Dermatol"},{"key":"73_CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ajhp\/58.1.41","volume":"58","author":"RW Barrons","year":"2001","unstructured":"Barrons RW: Treatment strategies for recurrent oral aphthous ulcers. Am J Health Syst Pharm 2001, 58:41\u201353.","journal-title":"Am J Health Syst Pharm"},{"key":"73_CR8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1085-5629(97)80017-X","volume":"16","author":"R Rogers","year":"1997","unstructured":"Rogers R: Recurrent aphthous stomatitis: clinical characteristics and associated systemic disorders. Sem Cutan Med Surg 1997, 16:278\u2013283.","journal-title":"Sem Cutan Med Surg"},{"key":"73_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1034\/j.1600-0714.2000.290104.x","volume":"29","author":"SS Natah","year":"2000","unstructured":"Natah SS, Hayrinen-Immonen R, Hietanen J, et al.: Immunolocalization of tumor necrosis factor-[alpha] expressing cells in recurrent aphthous ulcer lesions. J Oral Pathol Med 2000, 29:19\u201325.","journal-title":"J Oral Pathol Med"},{"key":"73_CR10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1034\/j.1600-0714.2001.300504.x","volume":"30","author":"S Sistig","year":"2001","unstructured":"Sistig S, Cecik-Arambasin A, Rabatic S, et al.: Natural immunity in recurrent aphthous ulceration. J Oral Pathol Med 2001, 30:275\u2013280. Molecular basis for the localized immunologic dysfunction that is believed to cause RAS. T-cell dysfunction appears to be the initial event, although the triggering factor remains unknown.","journal-title":"J Oral Pathol Med"},{"key":"73_CR11","first-page":"50","volume-title":"Burket\u2019s Oral Medicine. Diagnosis and Treatment","author":"MS Greenberg","year":"2003","unstructured":"Greenberg MS: Ulcerative, vesicular and bullous lesions. In Burket\u2019s Oral Medicine. Diagnosis and Treatment. Edited by Greenberg MS, Glick M. New York: BC Decker Inc.; 2003:50\u201384. Good review on the current thought on diagnosis and management of RAS."},{"key":"73_CR12","first-page":"324","volume":"12","author":"BC Muzyka","year":"2000","unstructured":"Muzyka BC: Diagnosis and treatment of recurrent aphthous ulceration. Prac Perio Aesthet Dent 2000, 12:324.","journal-title":"Prac Perio Aesthet Dent"},{"key":"73_CR13","first-page":"201","volume":"68","author":"D Eisen","year":"2001","unstructured":"Eisen D, Lynch DP: Selecting topical and systemic agents for recurrent aphthous stomatitis. Cutis 2001, 68:201\u2013206. Review on different therapeutic alternatives available to the clinician.","journal-title":"Cutis"},{"key":"73_CR14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1601-0825.1999.tb00062.x","volume":"5","author":"CM Healy","year":"1999","unstructured":"Healy CM, Paterson M, Joyston-Bechal S, et al.: The effect of sodium lauryl sulfate-free dentifrice on patients with recurrent oral ulceration. Oral Dis 1999, 5:39\u201343. One of the papers that disproved the theory of local allergic reaction or chemical sensitivity.","journal-title":"Oral Dis"},{"key":"73_CR15","first-page":"98","volume":"35","author":"S Padeh","year":"2000","unstructured":"Padeh S, Brezniak N, Zemer D, et al.: Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr 2000, 35:98\u2013101.","journal-title":"J Pediatr"},{"key":"73_CR16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2133.2000.03263.x","volume":"142","author":"P Herranz","year":"2000","unstructured":"Herranz P, Arribas JR, Navarro A, et al.: Successful treatment of aphthous ulcerations in AIDS patients using topical granulocyte-macrophage colony-stimulating factor. Br J Dermatol 2000, 142:171\u2013176.","journal-title":"Br J Dermatol"},{"key":"73_CR17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1079-2104(97)90009-3","volume":"83","author":"A Khandwala","year":"1997","unstructured":"Khandwala A, Van Inwegen RG, Alfano M: 5% Amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers. 1. Clinical demonstration of acceleration of healing and resolution of pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997, 83:222\u2013230.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"73_CR18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1034\/j.1600-0714.2001.301006.x","volume":"30","author":"LL Muzio","year":"2001","unstructured":"Muzio LL, della Valle A, Mignona MD, et al.: The treatment of oral aphthous ulceration or erosive lichen planus with topical clobetasol propionate in three preparations: a clinical and pilot study on 54 patients. J Oral Pathol Med 2001, 30:611\u2013617.","journal-title":"J Oral Pathol Med"},{"key":"73_CR19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0190-9622(98)70573-0","volume":"38","author":"EO Gilbertson","year":"1998","unstructured":"Gilbertson EO, Spellman MC, Piacquadio DJ, et al.: Super potent topical corticosteroid use associated with adrenal suppression. J Am Acad Dermatol 1998, 38:318\u2013321.","journal-title":"J Am Acad Dermatol"},{"key":"73_CR20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1079-2104(99)70134-4","volume":"87","author":"J Chandrasekhar","year":"1999","unstructured":"Chandrasekhar J, Liem AA, Cox NH, Paterson AW: Oxypentifyline in the management of recurrent aphthous oral ulcers: an open clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999, 87:564\u2013567. Clinical trial using PTX in the management of RAS with convincing results. This is the most recent of a series of papers that have studied the effects of PTX on RAS.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"73_CR21","first-page":"237","volume":"101","author":"A Pizarro","year":"1993","unstructured":"Pizarro A, Herranz P, Farrer M, Casado M: Recurrent oral aphthosis: treatment with pentoxifilline. Med Clin (Barc) 1993, 101:237.","journal-title":"Med Clin (Barc)"},{"key":"73_CR22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0167-5699(99)01531-5","volume":"20","author":"JB Marriott","year":"1999","unstructured":"Marriott JB, Muller G, Dalgleish AG: Thalidomide as an emerging immunotherapeutic agent. Immunol Today 1999, 20:538\u2013540.","journal-title":"Immunol Today"},{"key":"73_CR23","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","volume":"177","author":"Al Moreira","year":"1993","unstructured":"Moreira Al, Sampaio E, Zmuizinas A, et al.: Thalidomide exerts its inhibitory activity on tumor necrosis factor-alpha by enhancing mRNA degradation. J Exp Med 1993, 177:1675\u20131680.","journal-title":"J Exp Med"},{"key":"73_CR24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00000441-200105000-00004","volume":"321","author":"M Moraes","year":"2001","unstructured":"Moraes M, Russo G: Thalidomide and its dermatologic uses. Am J Med Sci 2001, 321:321\u2013326. Review of thalidomide and its applications, one of which is RAS.","journal-title":"Am J Med Sci"},{"key":"73_CR25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1086\/317928","volume":"183","author":"J Jacobson","year":"2001","unstructured":"Jacobson J, Greenspan JS, Spritzler J, et al.: Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers. J Infect Dis 2001, 183:343\u2013346.","journal-title":"J Infect Dis"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-003-0073-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-003-0073-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-003-0073-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:21:58Z","timestamp":1559434918000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-003-0073-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["73"],"URL":"https:\/\/doi.org\/10.1007\/s11908-003-0073-z","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}